Published in Transfusion on August 04, 2009
Detection of hepatitis B virus DNA among accepted blood donors in Nanjing, China. Virol J (2010) 0.97
Epidemiology of occult hepatitis B infection among thalassemic, hemophilia, and hemodialysis patients. Hepat Mon (2012) 0.94
Diagnostic strategy for occult hepatitis B virus infection. World J Gastroenterol (2011) 0.92
Factors in enhancing blood safety by nucleic acid technology testing for human immunodeficiency virus, hepatitis C virus and hepatitis B virus. Asian J Transfus Sci (2014) 0.87
Hepatitis B virus infection among first-time blood donors in Italy: prevalence and correlates between serological patterns and occult infection. Blood Transfus (2013) 0.82
The prevalence of hepatitis C virus infection and its related risk factors among the rural population of fars province, southern iran. Hepat Mon (2015) 0.81
Occult hepatitis B viral infection among blood donors in South-Eastern Nigeria. Pathog Glob Health (2014) 0.81
A pilot study on screening blood donors with individual-donation nucleic acid testing in China. Blood Transfus (2013) 0.79
Update on occult hepatitis B virus infection. World J Gastroenterol (2016) 0.75
The Prevalence of SEN Virus and Occult Hepatitis B (OBI) Virus Infection Among Blood Donors in Ahvaz City. Jundishapur J Microbiol (2016) 0.75
Comparison of the QIAGEN artus HBV QS-RGQ Assay With the Roche COBAS AmpliPrep/COBAS TaqMan HBV Assay for Quantifying Viral DNA in Sera of Chronic Hepatitis B Patients. Ann Lab Med (2017) 0.75
Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol (2008) 3.50
Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings. Transfusion (2005) 3.08
Effect of aging and physical activity on left ventricular compliance. Circulation (2004) 2.68
The global spread of hepatitis C virus 1a and 1b: a phylodynamic and phylogeographic analysis. PLoS Med (2009) 2.06
Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion. Transfusion (2009) 2.00
Long-term therapy with tenofovir is effective for patients co-infected with human immunodeficiency virus and hepatitis B virus. Gastroenterology (2010) 1.98
Fourth human parechovirus serotype. Emerg Infect Dis (2006) 1.75
Transfusion-transmitted hepatitis B virus infection. J Hepatol (2009) 1.70
Nucleic acid testing to detect HBV infection in blood donors. N Engl J Med (2011) 1.69
The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana. Blood (2002) 1.66
Long-term effects of irrigation with waste water on soil AM fungi diversity and microbial activities: the implications for agro-ecosystem resilience. PLoS One (2012) 1.53
Coxiella burnetii infection among blood donors during the 2009 Q-fever outbreak in The Netherlands. Transfusion (2011) 1.50
Frequent recovery and broad genotype 2 diversity characterize hepatitis C virus infection in Ghana, West Africa. J Virol (2003) 1.50
Infectivity of blood products from donors with occult hepatitis B virus infection. Transfusion (2013) 1.43
Identification and characterization of persistent human erythrovirus infection in blood donor samples. J Virol (2004) 1.43
Estimating the transfusion transmission risk of Q fever. Transfusion (2014) 1.42
Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa. Transfusion (2009) 1.41
Persistence of HTLV-I in blood components after leukocyte depletion. Blood (2002) 1.39
Persistent B19 infection in immunocompetent individuals: implications for transfusion safety. Blood (2005) 1.39
Results of the first World Health Organization international collaborative study of detection of human papillomavirus DNA. J Clin Microbiol (2006) 1.38
Cluster of cases of acute hepatitis associated with hepatitis E virus infection acquired in the Netherlands. Clin Infect Dis (2002) 1.37
Blood donor screening for parvovirus B19 in Germany and Austria. Transfusion (2007) 1.35
Follow-up of 686 patients with acute Q fever and detection of chronic infection. Clin Infect Dis (2011) 1.34
Emergency contraception use is correlated with increased condom use among adolescents: results from Mexico. J Adolesc Health (2004) 1.33
Multiplex real-time quantitative RT-PCR assay for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1. J Virol Methods (2004) 1.33
Anti-HBs positive occult hepatitis B virus carrier blood infectious in two transfusion recipients. J Hepatol (2008) 1.30
Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms. Transfusion (2010) 1.29
Diversity and origin of hepatitis C virus infection among unpaid blood donors in the Netherlands. Transfusion (2006) 1.29
Identification and genetic diversity of two human parvovirus B19 genotype 3 subtypes. J Gen Virol (2007) 1.28
Trypanosoma cruzi infection in North America and Spain: evidence in support of transfusion transmission. Transfusion (2012) 1.26
Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains. J Hepatol (2008) 1.25
Impact of hepatitis B virus surface protein mutations on the diagnosis of occult hepatitis B virus infection. Hepatology (2010) 1.23
Maternofetal transmission of hepatitis B virus genotype E in Ghana, west Africa. J Gen Virol (2007) 1.23
Dating the origin and dispersal of hepatitis B virus infection in humans and primates. Hepatology (2013) 1.19
Transfusional chagas disease: parasitological and serological monitoring of an infected recipient and blood donor. Clin Infect Dis (2008) 1.15
Sensitivity of HCV RNA and HIV RNA blood screening assays. Transfusion (2002) 1.15
Hepatitis B surface antigen declines and clearance during long-term tenofovir therapy in patients coinfected with HBV and HIV. J Infect Dis (2012) 1.12
Sensitivity of individual-donation and minipool nucleic acid amplification test options in detecting window period and occult hepatitis B virus infections. Transfusion (2013) 1.12
Hepatitis B virus transmission by blood transfusion during 4 years of individual-donation nucleic acid testing in South Africa: estimated and observed window period risk. Transfusion (2011) 1.10
HIV prevention in Mexican schools: prospective randomised evaluation of intervention. BMJ (2006) 1.09
Diagnostic algorithm for HBV safe transfusion. Blood Transfus (2009) 1.08
Human coronavirus NL63 and 229E seroconversion in children. J Clin Microbiol (2008) 1.07
Transfusion in sub-Saharan Africa: does a Western model fit? J Clin Pathol (2007) 1.06
Characterization of HBV DNA+/HBsAg- blood donors in Poland identified by triplex NAT. Hepatology (2006) 1.04
Occult hepatitis B infection: an evolutionary scenario. Virol J (2008) 1.03
Hepatitis C virus and hepatitis B virus bind to heparin: purification of largely IgG-free virions from infected plasma by heparin chromatography. J Gen Virol (2005) 1.03
HIV escape from natural killer cytotoxicity: nef inhibits NKp44L expression on CD4+ T cells. AIDS (2009) 1.03
Simultaneous visual detection of multiple viral amplicons by dipstick assay. J Clin Microbiol (2005) 1.02
Molecular characterization of occult hepatitis B virus in genotype E-infected subjects. J Gen Virol (2008) 1.01
Past and present of hepatitis E in the Netherlands. Transfusion (2014) 1.00
Travel-related dengue virus infection, The Netherlands, 2006-2007. Emerg Infect Dis (2011) 1.00
Molecular epidemiology of HIV in Ghana: dominance of CRF02_AG. J Med Virol (2004) 1.00
Protective effect of HLA-B57 on HCV genotype 2 infection in a West African population. J Med Virol (2007) 1.00
Full genome characterization of hepatitis B virus strains from blood donors in Iran. J Med Virol (2011) 1.00
Characterization of periplasmic protein BP26 epitopes of Brucella melitensis reacting with murine monoclonal and sheep antibodies. PLoS One (2012) 1.00
Head-to-head comparison of two transcription-mediated amplification assay versions for detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus Type 1 in blood donors. Transfusion (2013) 0.99
Occult hepatitis B infection in blood donors from South East Asia: molecular characterisation and potential mechanisms of occurrence. Gut (2012) 0.99
Characterization of occult hepatitis B virus strains in South African blood donors. Hepatology (2009) 0.99
HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomes. J Acquir Immune Defic Syndr (2013) 0.98
A novel hepatitis B virus subgenotype, D7, in Tunisian blood donors. J Gen Virol (2009) 0.98
External financial aid to blood transfusion services in sub-Saharan Africa: a need for reflection. PLoS Med (2012) 0.98
A cluster of human immunodeficiency virus Type 1 recombinant form escaping detection by commercial genomic amplification assays. Transfusion (2010) 0.97
Multiplex real-time PCR for the detection and quantification of latent and persistent viral genomes in cellular or plasma blood fractions. J Virol Methods (2008) 0.97
Evaluation of a new hepatitis B virus surface antigen rapid test with improved sensitivity. J Clin Microbiol (2008) 0.96
Acute hepatitis B virus window-period blood donations detected by individual-donation nucleic acid testing: a report on the first two cases found and interdicted in Spain. Transfusion (2006) 0.96
Transmissibility of hepatitis B virus (HBV) infection through blood transfusion from blood donors with occult HBV infection. Clin Infect Dis (2011) 0.95
Comparison of human immunodeficiency virus assays in window phase and elite controller samples: viral load distribution and implications for transmission risk. Transfusion (2013) 0.95
Enhanced detection of hepatitis B virus in Hong Kong blood donors after introduction of a more sensitive transcription-mediated amplification assay. Transfusion (2013) 0.95
Fatal human rabies due to Duvenhage virus from a bat in Kenya: failure of treatment with coma-induction, ketamine, and antiviral drugs. PLoS Negl Trop Dis (2009) 0.94
A probable case of hepatitis B virus transfusion transmission revealed after a 13-month-long window period. Transfusion (2008) 0.94
Human coronavirus 229E encodes a single ORF4 protein between the spike and the envelope genes. Virol J (2006) 0.93
Nucleic acid testing (NAT) in high prevalence-low resource settings. Biologicals (2010) 0.93
Prevalence of persistent and latent viruses in untreated patients infected with HIV-1 from Ghana, West Africa. J Med Virol (2009) 0.93
Comparison of the performance of IFA, CFA, and ELISA assays for the serodiagnosis of acute Q fever by quality assessment. Diagn Microbiol Infect Dis (2012) 0.93
Duplex molecular assay intended for point-of-care diagnosis of influenza A/B virus infection. J Clin Microbiol (2013) 0.92
The efficacy of individual-donation and minipool testing to detect low-level hepatitis B virus DNA in Taiwan. Transfusion (2009) 0.92
Baseline hepatitis B surface antigen (HBsAg) as predictor of sustained HBsAg loss in chronic hepatitis B patients treated with pegylated interferon-α2a and adefovir. Antivir Ther (2013) 0.92
Transient occult hepatitis B virus infection in a blood donor with high viremia. Transfusion (2009) 0.92
Quantitative real-time detection of parvovirus B19 DNA in plasma. Transfusion (2004) 0.90
Hepatitis B virus (HBV) infection and recombination between HBV genotypes D and E in asymptomatic blood donors from Khartoum, Sudan. J Clin Microbiol (2010) 0.89
Characterization of occult hepatitis B virus infection from blood donors in China. J Clin Microbiol (2011) 0.89
Differential reactivity of putative genotype 2 hepatitis C virus F protein between chronic and recovered infections. J Gen Virol (2008) 0.89